Themis Bioscience GmbH (THISR):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Themis Bioscience GmbH (THISR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10627
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Themis Bioscience GmbH (Themis Bioscience) is a biotechnology company that develops prophylactic vaccines for emerging tropical infections. The company develops emerging and specialist indications and vaccines from preclinical to late-stage clinical development phases. It develops novel vaccine candidates using its proprietary Themaxyn vaccine platform with a vaccine vector system, loaded with antigens from a variety of non – infectious and infectious targets. Themis Bioscience develops innovative vaccine candidates for infectious diseases such as dengue, chikungunya and yellow fever virus. The company markets its products in Austria and abroad. Themis Bioscience is headquartered in Vienna, Austria.

Themis Bioscience GmbH (THISR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Themis Bioscience GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Themis Bioscience Raises USD12 Million in Series C Venture Financing 10
Themis Bioscience Secures USD10.58 Million in Series B Funding Round 11
Themis Bioscience Raises USD7.8 Million in Series B Financing 12
Partnerships 13
Themis Bioscience Enters into Partnership with CEPI 13
Licensing Agreements 14
Themis Bioscience Enters into Licensing Agreement with Max Planck Innovation 14
Equity Offering 15
Themis Bioscience Postpones IPO 15
Themis Bioscience GmbH – Key Competitors 16
Themis Bioscience GmbH – Key Employees 17
Themis Bioscience GmbH – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Feb 26, 2018: Themis Establishes Scientific Advisory Board of Experts in Virology and Vaccine Development 19
Product News 21
06/05/2017: NIAID-Sponsored Trial of Experimental Chikungunya Vaccine Begins 21
Clinical Trials 22
Apr 11, 2017: Zika Virus: Themis Bioscience Initiates Worldwide First Study With Live Attenuated Recombinant Vaccine 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Themis Bioscience GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Themis Bioscience GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Themis Bioscience Raises USD12 Million in Series C Venture Financing 10
Themis Bioscience Secures USD10.58 Million in Series B Funding Round 11
Themis Bioscience Raises USD7.8 Million in Series B Financing 12
Themis Bioscience Enters into Partnership with CEPI 13
Themis Bioscience Enters into Licensing Agreement with Max Planck Innovation 14
Themis Bioscience Postpones IPO 15
Themis Bioscience GmbH, Key Competitors 16
Themis Bioscience GmbH, Key Employees 17

List of Figures
Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Themis Bioscience GmbH (THISR):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kolorfusion International Inc:企業の戦略的SWOT分析
    Kolorfusion International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • P.F. Chang’s China Bistro, Inc.:企業の戦略・SWOT・財務情報
    P.F. Chang's China Bistro, Inc. - Strategy, SWOT and Corporate Finance Report Summary P.F. Chang's China Bistro, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Oil & Gas Development Co Ltd (OGDC):企業の財務・戦略的SWOT分析
    Oil & Gas Development Co Ltd (OGDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Veikkaus Oy:企業の戦略的SWOT分析
    Veikkaus Oy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Avingtrans Plc (AVG):企業の財務・戦略的SWOT分析
    Avingtrans Plc (AVG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Hepion Pharmaceuticals Inc (HEPA):企業の財務・戦略的SWOT分析
    Summary Hepion Pharmaceuticals Inc (Hepion) formerly known as ContraVir Pharmaceuticals Inc, is a biopharmaceutical company that offers development and commercialization of targeted antiviral therapies. The company provides pipeline product such as TXL, potent prodrug of antiviral tenofovir and CRV4 …
  • Orica Ltd:企業の戦略・SWOT・財務情報
    Orica Ltd - Strategy, SWOT and Corporate Finance Report Summary Orica Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Kingsgate Consolidated Limited:企業の戦略・SWOT・財務情報
    Kingsgate Consolidated Limited - Strategy, SWOT and Corporate Finance Report Summary Kingsgate Consolidated Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • CMA CGM SA:企業のM&A・事業提携・投資動向
    CMA CGM SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CMA CGM SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Reliance Steel & Aluminum Co:企業の戦略・SWOT・財務情報
    Reliance Steel & Aluminum Co - Strategy, SWOT and Corporate Finance Report Summary Reliance Steel & Aluminum Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Ricoh Imaging Co Ltd:企業の戦略的SWOT分析
    Ricoh Imaging Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Independence Group NL:企業のM&A・事業提携・投資動向
    Independence Group NL - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Independence Group NL Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Noble Life Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Noble Life Sciences Inc (Noble Life Sciences) is a contract research organization that offers vaccines, drugs, and medical device development services. The company provides preclinical services such as disease and animal models, drug pharmacology and exploratory toxicology, analytical and la …
  • First Horizon National Corporation:企業の戦略・SWOT・財務情報
    First Horizon National Corporation - Strategy, SWOT and Corporate Finance Report Summary First Horizon National Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Hydro One Ltd (H):企業の財務・戦略的SWOT分析
    Hydro One Ltd (H) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Nichias Corp (5393):企業の財務・戦略的SWOT分析
    Nichias Corp (5393) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • ViacomCBS Inc (VIAC):企業の財務・戦略的SWOT分析
    ViacomCBS Inc (VIAC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Cape Plc:石油・ガス:M&Aディール及び事業提携情報
    Summary Cape Plc (Cape), a subsidiary of Altrad Investment Authority Sas, is a critical industrial services provider. Its portfolio includes essential multi-disciplinary on-site, scaffolding and access, Insulation, coatings, integrated maintenance services, Project management, Tank repair, maintenan …
  • Aoyama Trading Co., Ltd.:企業の戦略・SWOT・財務情報
    Aoyama Trading Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aoyama Trading Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • India Glycols Ltd (INDIAGLYCO):企業の財務・戦略的SWOT分析
    India Glycols Ltd (INDIAGLYCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆